117 related articles for article (PubMed ID: 38744246)
1. Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis.
Gupta T; Antanaviciute A; Hyun-Jung Lee C; Ottakandathil Babu R; Aulicino A; Christoforidou Z; Siejka-Zielinska P; O'Brien-Ball C; Chen H; Fawkner-Corbett D; Geros AS; Bridges E; McGregor C; Cianci N; Fryer E; Alham NK; Jagielowicz M; Santos AM; Fellermeyer M; Davis SJ; Parikh K; Cheung V; Al-Hillawi L; Sasson S; Slevin S; Brain O; ; Fernandes RA; Koohy H; Simmons A
Cancer Cell; 2024 May; 42(5):797-814.e15. PubMed ID: 38744246
[TBL] [Abstract][Full Text] [Related]
2. Interferon-Gamma-Producing CD8
Sasson SC; Slevin SM; Cheung VTF; Nassiri I; Olsson-Brown A; Fryer E; Ferreira RC; Trzupek D; Gupta T; Al-Hillawi L; Issaias ML; Easton A; Campo L; FitzPatrick MEB; Adams J; Chitnis M; Protheroe A; Tuthill M; Coupe N; Simmons A; Payne M; Middleton MR; Travis SPL; ; Fairfax BP; Klenerman P; Brain O
Gastroenterology; 2021 Oct; 161(4):1229-1244.e9. PubMed ID: 34147519
[TBL] [Abstract][Full Text] [Related]
3. Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis.
Thomas MF; Slowikowski K; Manakongtreecheep K; Sen P; Samanta N; Tantivit J; Nasrallah M; Zubiri L; Smith NP; Tirard A; Ramesh S; Arnold BY; Nieman LT; Chen JH; Eisenhaure T; Pelka K; Song Y; Xu KH; Jorgji V; Pinto CJ; Sharova T; Glasser R; Chan P; Sullivan RJ; Khalili H; Juric D; Boland GM; Dougan M; Hacohen N; Li B; Reynolds KL; Villani AC
Nat Med; 2024 May; 30(5):1349-1362. PubMed ID: 38724705
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis.
Hone Lopez S; Kats-Ugurlu G; Renken RJ; Buikema HJ; de Groot MR; Visschedijk MC; Dijkstra G; Jalving M; de Haan JJ
Virchows Arch; 2021 Dec; 479(6):1119-1129. PubMed ID: 34338882
[TBL] [Abstract][Full Text] [Related]
5. Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy.
Luoma AM; Suo S; Williams HL; Sharova T; Sullivan K; Manos M; Bowling P; Hodi FS; Rahma O; Sullivan RJ; Boland GM; Nowak JA; Dougan SK; Dougan M; Yuan GC; Wucherpfennig KW
Cell; 2020 Aug; 182(3):655-671.e22. PubMed ID: 32603654
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of CD4
He JY; Kim YJ; Mennillo E; Rusu I; Bain J; Rao AA; Andersen C; Law K; Yang H; Tsui J; Shen A; Davidson B; Kushnoor D; Shi Y; Fan F; Cheung A; Zhang L; Fong L; Combes AJ; Pisco AO; Kattah MG; Oh DY
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38642938
[TBL] [Abstract][Full Text] [Related]
7. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
[TBL] [Abstract][Full Text] [Related]
8. Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis.
Sasson SC; Zaunders JJ; Nahar K; Munier CML; Fairfax BP; Olsson-Brown A; Jolly C; Read SA; Ahlenstiel G; Palendira U; Scolyer RA; Carlino MS; Payne MJ; Cheung VTF; Gupta T; Klenerman P; Long GV; Brain O; Menzies AM; Kelleher AD
Clin Exp Immunol; 2020 Dec; 202(3):335-352. PubMed ID: 32734627
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axis.
Lo JW; Cozzetto D; Alexander JL; Danckert NP; Madgwick M; Knox N; Sieh JYX; Olbei M; Liu Z; Ibraheim H; Blanco JM; Kudo H; Seoane RC; Possamai LA; Goldin R; Marchesi J; Korcsmaros T; Lord GM; Powell N
Nat Commun; 2023 Oct; 14(1):6719. PubMed ID: 37872166
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of curcumin on experimental colitis mediated by inhibiting CD8
Zhao HM; Han F; Xu R; Huang XY; Cheng SM; Huang MF; Yue HY; Wang X; Zou Y; Xu HL; Liu DY
World J Gastroenterol; 2017 Mar; 23(10):1804-1815. PubMed ID: 28348486
[TBL] [Abstract][Full Text] [Related]
11. Small intestine CD11c+ CD8+ T cells suppress CD4+ T cell-induced immune colitis.
Fujiwara D; Chen L; Wei B; Braun J
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G939-47. PubMed ID: 21436315
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells.
Palmen MJ; Wijburg OL; Kunst IH; Kroes H; van Rees EP
Clin Exp Immunol; 1998 May; 112(2):216-25. PubMed ID: 9649183
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
[TBL] [Abstract][Full Text] [Related]
14. Activation and transcriptional profile of monocytes and CD8
Gudd CLC; Au L; Triantafyllou E; Shum B; Liu T; Nathwani R; Kumar N; Mukherjee S; Dhar A; Woollard KJ; Yone Y; Pinato DJ; Thursz MR; Goldin RD; Gore ME; Larkin J; Khamri W; Antoniades CG; Turajlic S; Possamai LA
J Hepatol; 2021 Jul; 75(1):177-189. PubMed ID: 33631227
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D Inhibits Pro-Inflammatory T Cell Function in Patients With Inflammatory Bowel Disease.
Schardey J; Globig AM; Janssen C; Hofmann M; Manegold P; Thimme R; Hasselblatt P
J Crohns Colitis; 2019 Dec; 13(12):1546-1557. PubMed ID: 31051495
[TBL] [Abstract][Full Text] [Related]
16. Placenta-specific 8 limits IFNγ production by CD4 T cells in vitro and promotes establishment of influenza-specific CD8 T cells in vivo.
Slade CD; Reagin KL; Lakshmanan HG; Klonowski KD; Watford WT
PLoS One; 2020; 15(7):e0235706. PubMed ID: 32639988
[TBL] [Abstract][Full Text] [Related]
17. CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice.
Ménager-Marcq I; Pomié C; Romagnoli P; van Meerwijk JP
Gastroenterology; 2006 Dec; 131(6):1775-85. PubMed ID: 17087950
[TBL] [Abstract][Full Text] [Related]
18. IL-33 Drives Expansion of Type 2 Innate Lymphoid Cells and Regulatory T Cells and Protects Mice From Severe, Acute Colitis.
Ngo Thi Phuong N; Palmieri V; Adamczyk A; Klopfleisch R; Langhorst J; Hansen W; Westendorf AM; Pastille E
Front Immunol; 2021; 12():669787. PubMed ID: 34335571
[TBL] [Abstract][Full Text] [Related]
19. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
[TBL] [Abstract][Full Text] [Related]
20. mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile.
Hu S; Chen M; Wang Y; Wang Z; Pei Y; Fan R; Liu X; Wang L; Zhou J; Zheng S; Zhang T; Lin Y; Zhang M; Tao R; Zhong J
PLoS One; 2016; 11(4):e0154564. PubMed ID: 27128484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
